Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLH-2004 Treatment Protocol
NCT00426101Phase 3Completed
- Sponsor
- Karolinska University Hospital
- Start
- Jan 2004
- Primary completion
- Dec 2011
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine, prednisolone in hemophagocytic lymphohistiocytosis (HLH), sponsored by Karolinska University Hospital. Started Jan 2004; status: completed.
02
Drugs
cyclosporineprednisolone
03
Conditions
hemophagocytic lymphohistiocytosis (HLH)
Beyond the preview
Go deeper on NCT00426101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426101.